Crossmark

Increasing the Utility of Real-World Data to Inform Public Health Decision Making Through a US-based Private–Public Partnership: 10 Lessons Learned from a Principled Approach to Rapid Pandemic RWE Generation

Crossref DOI link: https://doi.org/10.1007/s43441-025-00748-4

Published Online: 2025-03-18

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gatto, Nicolle M.

Garry, Elizabeth M.

Wang, Melanie

Zariffa, Névine

Roe, Laura

Chakravarty, Aloka

Rivera, Donna
License Information

Text and Data Mining valid from 2025-03-18

Version of Record valid from 2025-03-18
More Information

Article History

Received: 11 October 2024

Accepted: 20 January 2025

First Online: 18 March 2025

Declarations

:

: This paper reflects the views of the authors and should not be construed to represent FDA views or policies. Dr. Gatto, Dr. Garry and Ms. Wang are employees of Aetion, Inc., with stock options. During the design, analysis, and interpretation of the research project, Ms. Roe and Ms. Zariffa were affiliated with the U.S. Food and Drug Administration. All other authors declared no competing interests for this work.

Document is current

Any future updates will be listed below